MaxCyte Inc (MXCT)
NASDAQ:MXCT
Holding MXCT?
Track your performance easily

MaxCyte (MXCT) Technical Analysis

52 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
MaxCyte Inc’s (MXCT) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting MaxCyte Inc is a Sell.
MaxCyte Inc’s (MXCT) 20-Day exponential moving average is 4.11, while MaxCyte Inc’s (MXCT) share price is $4.1, making it a Buy.
MaxCyte Inc’s (MXCT) 50-Day exponential moving average is 4.20, while MaxCyte Inc’s (MXCT) share price is $4.1, making it a Buy.

MaxCyte (MXCT) Pivot Points

Sep 21, 2024, 10:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.69
3.84
3.95
4.10
4.21
4.36
4.47
Fibonacci
3.84
3.94
4.00
4.10
4.20
4.26
4.36
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MaxCyte (MXCT) Moving Averages

Sep 21, 2024, 10:00 AM
Period
Simple
Exponential
MA5
4.13Buy
4.15Buy
MA10
4.01Buy
4.10Buy
MA20
4.10Buy
4.11Buy
MA50
4.30Buy
4.20Buy
MA100
4.33Buy
4.25Buy
MA200
4.45Sell
4.25Buy
MaxCyte Inc’s (MXCT) 10-Day exponential moving average is 4.10, while MaxCyte Inc’s (MXCT) share price is $4.1, making it a Buy.
MaxCyte Inc’s (MXCT) 100-Day exponential moving average is 4.25, while MaxCyte Inc’s (MXCT) share price is $4.1, making it a Buy.
MaxCyte Inc’s (MXCT) stock price is $4.1 and MaxCyte Inc’s (MXCT) 50-day simple moving average is 4.30, creating a Buy signal.
MaxCyte Inc’s (MXCT) stock price is $4.1 and MaxCyte Inc’s (MXCT) 100-day simple moving average is 4.33, creating a Buy signal.
MaxCyte Inc’s (MXCT) stock price is $4.1 and MaxCyte Inc’s (MXCT) 200-day simple moving average is 4.45, creating a Sell signal.

MaxCyte (MXCT) Technical Indicators

Sep 21, 2024, 10:00 AM
Name
Value
Implied Action
RSI (14)
58.02
Neutral
STOCH (9,6)
75.29
Neutral
STOCHRSI (14)
63.38
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
13.08
Buy
Williams %R
-11.27
Sell
CCI (14)
88.88
Neutral
ATR (14)
0.24
-
Ultimate Oscillator
52.31
Neutral
ROC
0.93
Buy
MaxCyte Inc’s (MXCT) Relative Strength Index (RSI) is 58.02, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Trend Strength Indicator (ADX) is 13.08, creating a Buy signal.
MaxCyte Inc’s (MXCT) Commodity Channel Index (CCI) is 88.88, creating a Neutral signal.
MaxCyte Inc’s (MXCT) Price Rate of Change (ROC) is 0.93, creating a Buy signal.

FAQ

Is MXCT a Buy, Hold, or Sell?
Based on MXCT’s technical indicators, MXCT is a Buy.
    What is MXCT’s RSI (14)?
    MXCT’s RSI (14) is 58.02, which suggests MXCT is a Neutral.
      What is MXCT’s MACD?
      MXCT’s MACD is -0.03, which suggests MXCT is a Sell.
        What is MXCT’s 5-day moving average?
        MXCT’s 5-day moving average is 4.13, which suggests MXCT is a Buy.
          What is MXCT’s 20-day moving average?
          MXCT 20-day moving average is 4.10, which suggests MXCT is a Buy.
            What is MXCT’s 50-day moving average?
            MXCT’s 50-day moving average is 4.30, which suggests MXCT is a Buy.
              What is MXCT’s 200-day moving average?
              MXCT’s 200-day moving average is 4.45, which suggests MXCT is a Sell.
                What is MXCT’s Williams % R (14)?
                MXCT’s Williams % R (14) is -11.27, which suggests MXCT is a Sell.
                  What is MXCT’s CCI (14)?
                  MXCT’s CCI (14) is 88.88, which suggests MXCT is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis